Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase 3 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 109 Paclitaxel 65 Cyclophosphamide 65 Cisplatin 60 Carboplatin 56 Gemcitabine 48 Radiotherapy 45 Nivolumab 44 fludarabine 38 Docetaxel 38 Pemetrexed 33 Dexamethasone 32 Capecitabine 32 Lenalidomide 26 fludarabine phosphate 25 Rituximab 25 Radiation 25 Ipilimumab 25 Doxorubicin 25 Irinotecan 24 Bevacizumab 24 Azacitidine 24 Vorinostat 23 Vincristine 22 Cytarabine 22 Temozolomide 20 Etoposide 20 Oxaliplatin 19 Fluorouracil 19 atezolizumab 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Has results × Epothilones × Clear all

NCT00322374 2016-03-10

Phase I Combination w/ Epirubicin

R-Pharm

Phase 1 Completed

42 enrolled 24 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡